Recruiting Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors NCT07080242 Conditions Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +18 more Locations Clearview Cancer Institute — Huntsville, Alabama, United States Valkyrie Clinical Trials — Los Angeles, California, United States UCLA — Los Angeles, California, United States UCSF- San Francisco (Helen Diller Family Comprehensive Cancer Center) — San Francisco, California, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. NCT06379217 Conditions Metastatic Neuroendocrine Prostate Cancer Locations Nebraska Cancer Specialists — Omaha, Nebraska, United States Memorial Sloan Kettering Cancer Ctr — New York, United States Novartis Investigative Site — Nantes, France Novartis Investigative Site — München, Germany View more locations Show fewer locations Loading locations... View Trial Details
